Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of type 2 diabetes. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://lilianaiyo230107.life3dblog.com/37576896/semaglutide-a-potential-solution-for-obesity